Pharmaceuticals

Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Cardiac Biomarkers Testing Market Is Supporting Development Across The Cardiac Biomarkers Testing Market

May 18, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Cardiac Biomarkers Testing Market Between 2026 And 2030?

The market size for cardiac biomarkers testing has experienced rapid growth in recent years. This market is projected to expand from $14.95 billion in 2025 to $16.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth has been fueled by factors such as an increasing incidence of cardiovascular diseases, greater public awareness concerning cardiac health, continuous advancements in laboratory diagnostics, the expansion of hospital infrastructure, and a rise in government-led healthcare initiatives.

The cardiac biomarkers testing market is poised for significant expansion in the coming years. By 2030, its valuation is expected to climb to $25.92 billion, demonstrating a compound annual growth rate (CAGR) of 11.6%. This projected increase is fueled by the growing integration of AI in diagnostic processes, the spread of home-based and remote patient monitoring, the evolution of precision medicine, the development of diverse multi-biomarker panels, and a heightened demand for real-time cardiac surveillance. Noteworthy trends anticipated during this period include a wider embrace of point-of-care testing, the emergence of miniaturized and portable diagnostic instruments, advancements in biomarker multiplexing technologies, personalized cardiac risk assessment, and the seamless incorporation of wearables for ongoing heart monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

Which Major Factors Are Contributing To The Development Of The Cardiac Biomarkers Testing Market?

The rising incidence of cardiovascular diseases is anticipated to fuel the expansion of the cardiac biomarkers testing market. These conditions involve affections of the heart or blood vessels. Cardiac biomarker tests are instrumental in measuring biomarker levels to quickly ascertain the severity and magnitude of a heart attack. Consequently, a surge in cardiovascular disease prevalence will inevitably lead to heightened demand for cardiac biomarker testing solutions. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported an increase in the age-adjusted death rate from cardiovascular disease to 233.3 per 100,000 in 2024, marking a 4.0% rise from 224.4 per 100,000 in 2023. Therefore, the growing prevalence of cardiovascular diseases is a primary driver for the growth observed in the cardiac biomarkers testing market.

What Key Segment Areas Are Included In The Cardiac Biomarkers Testing Market Assessment?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Which Trends Are Shaping The Cardiac Biomarkers Testing Market Landscape?

Key companies in the cardiac biomarker testing market are forming strategic alliances to deliver technology for the early detection of heart conditions and to improve patient outcomes. Such collaborations in cardiac biomarker testing promote cooperation among companies, facilitating the creation of innovative diagnostics, expanding their market presence, and accelerating the deployment of advanced testing solutions for enhanced cardiovascular care. For example, in September 2024, MediBuddy, an Indian-based healthcare technology firm offering a comprehensive platform for telehealth services, health management, and insurance assistance, entered into a partnership with Philips, a Netherlands-based conglomerate corporation. Through this collaboration, they intend to improve cardiac care in India by integrating Philips’ HeartPrint technology, which enables ongoing monitoring and risk assessment of heart health. This innovative approach provides users with sophisticated tools on the MediBuddy platform, encouraging proactive management of heart health and leading to better results.

Who Are The Major Companies Operating In The Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Access The Complete Cardiac Biomarkers Testing Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Which Region Stands As The Largest Contributor To The Cardiac Biomarkers Testing Market?

North America was the largest region in the cardiac biomarkers testing market in 2025. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cardiac Biomarkers Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

Browse Through More Reports Similar to the Global Cardiac Biomarkers Testing Market 2026, By The Business Research Company

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795